By Gordon Woodworth, Chronicle News Editor
“I didn’t cry when I was sick, but now I’m crying and it’s tears of joy,” says Queensbury schoolteacher Tina Bureau.
Diagnosed a year ago with an aggressive non-Hodgkin’s lymphoma that did not respond to chemotherapy, Mrs. Bureau accepted a chance to participate in an experimental immunotherapy clinical trial at Dana-Farber Cancer Institute in Boston.
The treatment, called Yescarta and made by Los Angeles-based …
Read More »